AR131633A1 - Derivados novedosos de pirimidinil sulfonamida - Google Patents

Derivados novedosos de pirimidinil sulfonamida

Info

Publication number
AR131633A1
AR131633A1 ARP240100112A ARP240100112A AR131633A1 AR 131633 A1 AR131633 A1 AR 131633A1 AR P240100112 A ARP240100112 A AR P240100112A AR P240100112 A ARP240100112 A AR P240100112A AR 131633 A1 AR131633 A1 AR 131633A1
Authority
AR
Argentina
Prior art keywords
sulfonamide derivatives
novel
novel pyrimidinyl
pyrimidinyl sulfonamide
compounds
Prior art date
Application number
ARP240100112A
Other languages
English (en)
Inventor
Guido Galley
Luca Gobbi
Dmitry Mazunin
Emmanuel Pinard
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR131633A1 publication Critical patent/AR131633A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invención se refiere a compuestos novedosos que tienen la fórmula general (1) en donde R¹, R², R³, R⁴, R⁵ y R⁶ son como se describe en la presente, una composición que incluye los compuestos y métodos para usar los compuestos.
ARP240100112A 2023-01-20 2024-01-18 Derivados novedosos de pirimidinil sulfonamida AR131633A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP23152565 2023-01-20

Publications (1)

Publication Number Publication Date
AR131633A1 true AR131633A1 (es) 2025-04-16

Family

ID=85019036

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP240100112A AR131633A1 (es) 2023-01-20 2024-01-18 Derivados novedosos de pirimidinil sulfonamida

Country Status (7)

Country Link
US (1) US20250346580A1 (es)
EP (1) EP4652158A1 (es)
JP (1) JP2026502630A (es)
CN (1) CN120530103A (es)
AR (1) AR131633A1 (es)
TW (1) TW202434245A (es)
WO (1) WO2024153724A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI4298092T1 (sl) 2021-02-26 2026-04-30 F. Hoffmann-La Roche Ag Novi derivati pirimidin-2-il sulfonamida
US20240299385A1 (en) 2021-06-04 2024-09-12 Rewind Therapeutics Nv 3-pyrrolylsulfonamide compounds as gpr17 antagonists

Also Published As

Publication number Publication date
EP4652158A1 (en) 2025-11-26
TW202434245A (zh) 2024-09-01
WO2024153724A1 (en) 2024-07-25
CN120530103A (zh) 2025-08-22
JP2026502630A (ja) 2026-01-23
US20250346580A1 (en) 2025-11-13

Similar Documents

Publication Publication Date Title
AR130984A1 (es) Compuestos novedosos
AR131278A1 (es) Compuestos novedosos
AR131006A1 (es) Compuestos novedosos
AR131282A1 (es) Compuestos novedosos
AR123424A1 (es) Nuevos compuestos heterocíclicos
CL2024004085A1 (es) Compuestos macrocíclicos inhibidores de kras, uso para tratar cáncer.
AR132377A1 (es) Compuestos novedosos
AR132340A1 (es) Compuestos tricíclicos para el tratamiento de cáncer
CL2023003312A1 (es) Inhibidores de nlrp3
CO2023016212A2 (es) Derivados de triazina y su uso en el tratamiento del cáncer
ECSP20044709A (es) Inhibidores de sarcómero cardíaco
CL2023003154A1 (es) Compuestos heterocíclicos
CL2023002429A1 (es) Derivados novedosos de pirimidin-2-il sulfonamida
MX2021005714A (es) Nuevos compuestos heterociclicos.
AR116283A1 (es) Inhibidores del sarcómero cardíaco
CO2023013321A2 (es) Compuestos de oxoisoindolina sustituidos con piridinilo
CR20220638A (es) Derivados de amidopirimidona
CO2025002028A2 (es) Derivados novedosos de indol sulfonamida 7 sustituidos
AR132456A1 (es) Compuestos novedosos
CL2025000125A1 (es) Compuestos derivados de indolsulfonamida y uso para tratar pérdida de mielina.
CO2025003256A2 (es) Derivados novedosos deuterados de pirimidin-2-il sulfonamida
CL2023002908A1 (es) Compuestos heterocíclicos de arilo como bloqueadores del canal agitador de potasio kv1.3
CO2022012773A2 (es) Moduladores de nampt
AR133167A1 (es) Macrociclos para el tratamiento de enfermedad autoinmunitaria
AR133375A1 (es) Compuestos novedosos